Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- PMID: 28252261
- DOI: 10.1056/NEJMc1615712
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Comment in
-
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Clinical Trial.
-
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2017 Mar 2;376(9):891-2. doi: 10.1056/NEJMc1615712. N Engl J Med. 2017. PMID: 28249135 No abstract available.
Comment on
-
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical